| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | EVP, Chief Financial Officer
1 company
Dickinson Andrew D is a Chief Financial Officer at GILD. Recent filings cover 0 purchases and 23 sales. Those positions are worth an estimated $24.3M at current prices.
Our model assigns Dickinson Andrew D a below-average insider score of 42/100, based on 21 past trades. Over a 12-month horizon, 7.1% of those trades were profitable, with an average 12-month return of -25.9%.
Dickinson Andrew D's largest disclosed position is in GILD as Chief Financial Officer, worth about $24.3M. The recent filings there lean toward selling, a net 603,430 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sell | 2,500 | $110.53 | $276,325.00 | -1.4% | -1.3% | +28.6% | |
| Mar 10, 2025 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sale+OE | 17,929 | $118.17 | $2,118,695.72 | -4.9% | -3.6% | +26.8% | |
| Feb 18, 2025 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sell | 2,500 | $104.09 | $260,225.00 | -1.5% | +0.9% | +45.1% | |
| Feb 12, 2025 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sale+OE | 137,676 | $102.22 | $14,073,240.72 | -44.6% | -1.8% | +46.9% | |
| Jan 31, 2025 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sale+OE | 142,180 | $97.22 | $13,822,739.60 | -52.3% | +6.2% | +46.0% | |
| Jan 15, 2025 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sell | 2,500 | $91.35 | $228,375.00 | -1.9% | +14.4% | +31.3% | |
| Dec 16, 2024 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sell | 8,500 | $91.96 | $781,660.00 | -6.0% | +22.0% | +29.0% | |
| Nov 29, 2024 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sale+OE | 248,645 | $92.76 | $23,065,270.54 | -38.0% | +21.0% | +35.9% | |
| Jan 16, 2024 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sell | 5,000 | $85.78 | $428,900.00 | -4.7% | -21.2% | +7.4% | |
| Oct 17, 2023 | GILD Gilead Sciences, Inc. | Chief Financial Officer | Sell | 5,000 | $80.00 | $400,017.00 | -4.6% | +6.8% | +7.8% |